logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
H

Haifa Kathrin Al-Ali

university hospital halle
H指数:38
被引数:9,439

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

DECIDER-2: Prospective randomized multicenter phase III trial of decitabine and venetoclax administered in combination with all-trans retinoic acid or placebo in patients with acute myeloid leukemia who are ineligible for induction chemotherapy

DECIDER-2：一项前瞻性随机多中心III期临床试验，评估地西他滨联合维奈克拉在所有-trans维甲酸或安慰剂中给予急性髓系白血病患者的疗效，这些患者不适合诱导化疗

BMC Cancer
IF3.4
2026-08-050
OA
Olga Grishina; Claudia Schmoor; Caroline Sellner; Björn Hackanson; Jan-Henrik Mikesch; Iordanis Deligiannis; Felicitas Thol; Martina Crysandt; Christian Junghanss; Volker Runde; Paul La Rosée; Lino Lars Teichmann; Haifa Kathrin Al-Ali; Tim Sauer; Ulrich Germing; Frank Griesinger; Stefan Lukic; Jürgen Krauter; Snjezana Janjetovic; Jan Koch; Peter Staib; Julian Topaly; Maike de Wit; Doris Maria Kraemer; Lorenz Oelschläger; Ulf Schnetzke; Oliver Schmah; Swen Wessendorf; Cyrus Khandanpour; Lukas Kündgen; Monika Schwalenberg; Michael Heuser; Arnold Ganser; Hartmut Döhner; Ralph Wäsch; Michael Lübbert
Association of the composition of the bone marrow tumor microenvironment in BCR::ABL1-negative myeloproliferative neoplasms with IFN-γ signaling and driver mutations

BCR::ABL1阴性骨髓增殖性肿瘤中骨髓肿瘤微环境组成与IFN-γ信号通路及驱动基因突变的相关性

Leukemia
IF13.4
2025-08-050
OAAI
Marcus Bauer; Christoforos Vaxevanis; Nadja Jaekel; Hubert Hackl; Andreas Wilfer; Clara Zoellig; Monika Haemmerle; Carsten Müller-Tidow; Haifa Kathrin Al-Ali; Barbara Seliger; Claudia Wickenhauser
ROP-ET: A Prospective Phase III Trial Investigating the Efficacy and Safety of Ropeginterferon Alfa-2b in Essential Thrombocythemia Patients with Limited Treatment Options

ROP-ET：一项前瞻性III期试验，旨在研究罗普司坦alfa-2b在治疗治疗选择有限的真性红细胞增多症患者中的有效性和安全性

BLOOD
IF23.1
2024-11-050
OA
Kiladjian, Jean-Jacques; Marin, Francisca Ferrer; Al-Ali, Haifa Kathrin; Alvarez-Larran, Alberto; Beggiato, Eloise; Bieniaszewska, Maria; Breccia, Massimo; Buxhofer-Ausch, Veronika; Cerna, Olga; Crisan, Ana Manuela; Danaila, Catalin; De Stefano, Valerio; Dohner, Konstanze; Empson, Victoria; Tybor, Joanna Gora; Griesshammer, Martin; Grosicki, Sebastian; Guglielmelli, Paola; Gutierrez Sr, Valentin Garcia; Heidel, Florian; Illes, Arpad; James, Chloe; Koschmieder, Steffen; Maria-Theresa, Krauth; Krejcy, Kurt; Lazaroiu, Mihaela Cornelia; Mayer, Jiri; Nagy, Zsolt; Palandri, Francesca; Pappa, Vasiliki; Reiter, Andreas; Sacha, Tomasz; Schlager, Stefanie; Schmidt, Stefan Ulrich; Terpos, Evangelos; Tomuleasa, Ciprian; Torregrosa, Jose Miguel; Unger, Martin; Woelfler, Albert; Xicoy, Blanca; Klade, Christoph
POIESIS: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Global Phase 3 Study of Navtemadlin As Add-on to Ruxolitinib in JAK Inhibitor-Naive Patients with Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

POIESIS：一项随机、双盲、安慰剂对照、多中心、全球性III期研究，评估纳特梅达林（Navtemadlin）作为鲁索利替尼（Ruxolitinib）加用疗法在鲁索利替尼无应答的骨髓纤维化患者中的疗效，该患者群体对鲁索利替尼反应欠佳。

BLOOD
IF23.1
2024-11-050
PRE
Vachhani, Pankit; Rampal, Raajit; Bradley, Terrence; Harrison, Claire; Jain, Tania; Kuykendall, Andrew T.; Palandri, Francesca; Mascarenhas, John O.; Al-Ali, Haifa Kathrin; Passamonti, Francesco; Nekhymchuk, Anna; Foss, Hilarie; Rothbaum, Wayne; Verstovsek, Srdan; Heidel, Florian
Efficacy and safety of fedratinib in patients with myelofibrosis previously treated with ruxolitinib (FREEDOM2): results from a multicentre, open-label, randomised, controlled, phase 3trial
LANCET HAEMATOLOGY
IF17.7
2024-10-013
PRE
Harrison, Claire N.; Mesa, Ruben; Talpaz, Moshe; Al-Ali, Haifa Kathrin; Xicoy, Blanca; Passamonti, Francesco; Palandri, Francesca; Benevolo, Giulia; Vannucchi, Alessandro Maria; Mediavilla, Clemence; Iurlo, Alessandra; Kim, Inho; Rose, Shelonitda; Brown, Patrick; Hernandez, Christopher; Wang, Jia; Kiladjian, Jean-Jacques
NCCN guideline-concordant cancer care in sub-Saharan Africa: a population-based multicountry study of 5 cancers
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
IF7.2
2024-09-120
OAAI
Mezger, Nikolaus Christian Simon; Seraphin, Tobias Paul; Balle, Robert; Griesel, Mirko; Joko-Fru, Yvonne Walburga; Haemmerl, Lucia; Feuchtner, Jana; Liu, Biying; Zietsman, Annelle; Kamate, Bakarou; Gnangnon, Freddy Houehanou Rodrigue; Gnahatin, Franck; Mboungou, Dimitry Moudiongui; Assefa, Mathewos; Amulen, Phoebe Mary; Chesumbai, Gladys; Chingonzoh, Tatenda; Lorenzoni, Cesaltina Feirreira; Korir, Anne; Carvalho Santos, Pablo S.; Mezger, Joerg Michael; Al-Ali, Haifa Kathrin; Mikolajczyk, Rafael; Parkin, Donald Max; Jemal, Ahmedin; Kantelhardt, Eva Johanna
Hematopoietic cell transplantation for older acute myeloid leukemia patients in first complete remission: results of a randomized phase III study

首次完全缓解的老年急性髓性白血病患者的造血细胞移植: 一项随机III期研究的结果

HAEMATOLOGICA
IF7.9
2024-08-081
OAAI
Niederwieser, Dietger; Hasenclever, Dirk; Berdel, Wolfgang E.; Biemond, Bart J.; Al-Ali, Haifa; Chalandon, Yves; van Gelder, Michel; Junghanss, Christian; Gahrton, Goesta; Haenel, Mathias; Hehlmann, Ruediger; Heinicke, Thomas; Hochhaus, Andreas; Iacobelli, Simona; Kooy, Rien van Marwijk; Kroeger, Nicolaus; Janssen, Jeroen; Jentzsch, Madlen; Breywisch, Frank; Mohty, Mohamad; Masouridi-Levrat, Stavroula; Ossenkoppele, Gert; Passweg, Jacob; Poenisch, Wolfram; Schetelig, Johannes; Schliemann, Christoph; Schwind, Sebastian; Stelljes, Matthias; Verdonck, Leo F.; Vucinic, Vladan; Lowenberg, Bob; Cornelissen, Jan
FRACTION: protocol of a phase II study of Fedratinib and Nivolumab combination in patients with myelofibrosis and resistance or suboptimal response to JAK-inhibitor treatment of the German MPN study group (GSG-MPN)

分数: 德国MPN研究组 (gsg-mpn) 的骨髓纤维化和对JAK抑制剂治疗的耐药性或次优反应患者的Fedratinib和Nivolumab组合的II期研究方案

ANNALS OF HEMATOLOGY
IF2.4
2024-07-053
OAAI
Isfort, Susanne; von Bubnoff, Nikolas; Al-Ali, Haifa Kathrin; Becker, Heiko; Goetze, Thorsten; le Coutre, Philipp; Griesshammer, Martin; Moskwa, Claudia; Wohn, Luisa; Riedel, Johanna; Palandri, Francesca; Manz, Kirsi; Hochhaus, Andreas; Doehner, Konstanze; Heidel, Florian H.
ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options
ANNALS OF HEMATOLOGY
IF2.4
2024-03-044
OAAI
Kiladjian, Jean-Jacques; Marin, Francisca Ferrer; Al-Ali, Haifa Kathrin; Alvarez-Larran, Alberto; Beggiato, Eloise; Bieniaszewska, Maria; Breccia, Massimo; Buxhofer-Ausch, Veronika; Cerna, Olga; Crisan, Ana-Manuela; Danaila, Catalin Doru; De Stefano, Valerio; Doehner, Konstanze; Empson, Victoria; Gora-Tybor, Joanna; Griesshammer, Martin; Grosicki, Sebastian; Guglielmelli, Paola; Garcia-Gutierrez, Valentin; Heidel, Florian H.; Illes, Arpad; Tomuleasa, Ciprian; James, Chloe; Koschmieder, Steffen; Krauth, Maria-Theresa; Krejcy, Kurt; Lazaroiu, Mihaela-Cornelia; Mayer, Jiri; Nagy, Zsolt Gyoergy; Nicolini, Franck-Emmanuel; Palandri, Francesca; Pappa, Vassiliki; Reiter, Andreas Johannes; Sacha, Tomasz; Schlager, Stefanie; Schmidt, Stefan; Terpos, Evangelos; Unger, Martin; Woelfler, Albert; Cirici, Blanca Xicoy; Klade, Christoph
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis previously treated with a JAK inhibitor (MOMENTUM): an updated analysis of an international, double-blind, randomised phase 3 study
LANCET HAEMATOLOGY
IF17.7
2023-09-0116
PRE
Gerds, Aaron T.; Verstovsek, Srdan; Vannucchi, Alessandro M.; Al-Ali, Haifa Kathrin; Lavie, David; Kuykendall, Andrew; Grosicki, Sebastian; Iurlo, Alessandra; Goh, Yeow Tee; Lazaroiu, Mihaela C.; Egyed, Miklos; Fox, Maria Laura; McLornan, Donal; Perkins, Andrew; Yoon, Sung-Soo; Gupta, Vikas; Kiladjian, Jean-Jacques; Granacher, Nikki; Lee, Sung-Eun; Ocroteala, Luminita; Passamonti, Francesco; Harrison, Claire N.; Oh, Stephen; Klencke, Barbara J.; Yu, Jing; Donahue, Rafe; Kawashima, Jun; Mesa, Ruben
Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study

第二代酪氨酸激酶抑制剂 (TKI) 治疗后慢性粒细胞白血病 (CML) 慢性期患者中博舒替尼的逐步剂量: 博舒替尼剂量优化 (BODO) 研究的结果

ANNALS OF HEMATOLOGY
IF2.4
2023-08-189
OAAI
Isfort, Susanne; Manz, Kirsi L.; Teichmann, Lino; Crysandt, Martina; Burchert, Andreas; Hochhaus, Andreas; Saussele, Susanne; Kiani, Alexander R.; Gothert, Joachim; Illmer, Thomas; Schafhausen, Philippe; Al-Ali, Haifa Kathrin; Stegelmann, Frank; Haenel, Mathias; Pfeiffer, Tim; Giagounidis, Aristoteles; Franke, Georg-Nikolaus; Koschmieder, Steffen; Fabarius, Alice; Ernst, Thomas; Warnken-Uhlich, Mareille; Wolber, Uta; Kohn, Denise; Pfirrmann, Markus; Wolf, Dominik H.; Bruemmendorf, Tim; German CML Study Grp

研究方向

暂未获取到该数据
D
Dietger Niederwieser
H 指数:103论文数:978被引数:6.1万
A
Alessandro M. Vannucchi
H 指数:109论文数:1,203被引数:5.2万
J
Jean‐Jacques Kiladjian
H 指数:71论文数:760被引数:2.8万
F
Francesca Palandri
H 指数:50论文数:536被引数:9,339
C
Claire Harrison
H 指数:80论文数:849被引数:3.4万
F
Francesco Passamonti
H 指数:90论文数:702被引数:3.9万
C
Christian Junghanß
H 指数:37论文数:354被引数:6,113
T
Thoralf Lange
H 指数:41论文数:253被引数:7,071
V
Vikas Gupta
H 指数:75论文数:896被引数:2.4万
R
Ruben A. Mesa
H 指数:96论文数:1,281被引数:4.5万